Improving Chemotherapy Induced Peripheral Neuropathy in Children With Leukemia: A Study of Transcutaneous Acupoints Electrical Stimulation and Auricular Acupressure Interventions

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-17
SponsorThe Hong Kong Polytechnic University

About this trial

The goal of this clinical trial is to compare the effectiveness of Transcutaneous Acupoints Electrical Stimulation (TAES) and Auricular Acupressure (AA) on subject CIPN symptoms, sensory function, motor and physical function, psychological, physical symptoms and quality of life outcomes in Children with Leukemia.

The main questions it aims to answer are:

1. Does TAES and AA can improve CIPN symptoms, sensory function, motor and physical function, psychological, physical symptoms and quality of life outcomes in children with Leukemia compared with self-management control group? 2. Does TAES yield improvements in CIPN symptoms, sensory function, motor and physical function, psychological, physical symptoms and quality of life outcomes that are comparable to those achieved through AA in children with leukemia?

This proposed research is designed to conduct a three-arm RCT comparing TAES, AA to usual care in children with leukemia.

Subjects in TAES group will receive 8 weeks TAES on four acupoints. Subjects in AA group will receive 8 weeks on four acupoints. Subjects in self-management control group will receive usual care they will receive from the hospital. These three groups will be provided with a leaflet containing self-help materials for CIPN.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

age between 8 and 17 years old

diagnosed with leukemia

received neurotoxic chemotherapy

have developed score 9 or above CIPN symptoms according to Pediatric Chemotherapy-Induced Neuropathy (P-CIN)

Disqualifiers

receiving multiple cancer treatment

had a diagnosis of cancer in the central nervous system cancer, cancer relapse or secondary cancer

having other neuromuscular disorders, for example, traumatic brain injury and cerebral palsy

having other systematic diseases that cause toxicity in the peripheral nervous system, such as sickle cell disease (SCD), Guillain-Barre ́ Syndrome (GBS), anterior cutaneous nerve entrapment syndrome (ACNES), obstetric brachial plexus injury (OBPI), type I diabetes mellitus, postherpetic neuralgia (PHN), peroneal nerve injury, and reflex sympathetic dystrophy (RSD)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Transcutaneous Acupoints Electrical Stimulation (TAES)

    Behavioral

    Transcutaneous Acupoints Electrical Stimulation (TAES) is a kind of physical therapy that use electric current through the electrodes placed on the surface of acupoints to produce clinical effects in the human body.

  • Auricular Acupressure (AA)

    Behavioral

    Auricular acupressure (AA) is a non-invasive therapy rooted in Traditional Chinese Medicine (TCM) that involves applying pressure to specific acupoints on the ear using Vaccaria seeds.

  • No intervention

    Other intervention

    No intervention

Treatment groups

132 Participants
are divided into 3 treatment groups
Group A: Transcutaneous Acupoints Electrical Stimulation (TAES)Experimental treatment 1 intervention
Group B: Auricular Acupressure (AA)Experimental treatment 1 intervention
Group C: Self-Managed control groupPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

CIPN severity - Pediatric Chemotherapy-Induced Neuropathy (P-CIN)

To evaluate the severity of CIPN. The Pediatric Chemotherapy-Induced Neuropathy scale contains 13 items, with eight items to rate CIPN symptoms in the hands and feet and five items to rate the difficulty of performing functional tasks. The total score ranges from 0 to 65 with higher scores indicating more severe CIPN.

Time frame
Baseline, immediately after intervention (T1), 1 month after intervention (T2), and 3 month after intervention (T3)

Secondary outcomes

1

Sensory function outcomes

Touch sensation were measured using monofilament examination with the best of both 2 trials on each side averaged.

Time frame
Baseline, immediately after intervention (T1), 1 month after intervention (T2), and 3 month after intervention (T3)
2

Sensory function outcomes

Vibration sensation were measured using a 128 Hz tuning fork, with the best of both 2 trials on each side averaged.

Time frame
Baseline, immediately after intervention (T1), 1 month after intervention (T2), and 3 month after intervention (T3)
3

Motor and physical function

Timed Up and Go test (TUG) will be used to evaluate the motor and physical function in children with leukemia.

Time frame
Baseline, immediately after intervention (T1), 1 month after intervention (T2), and 3 month after intervention (T3)
4

Motor and physical function

30-second sitting-rising test will be used to evaluate the motor and physical function in children with leukemia.

Time frame
Baseline, immediately after intervention (T1), 1 month after intervention (T2), and 3 month after intervention (T3)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

The Hong Kong Polytechnic University

Lead sponsor

Shanghai Children's Medical Center

Collaborator

This trial is not recruiting at the moment. You can still explore other options: